Most Read Articles
4 days ago
The use of capsule endoscopy (CE) appears to be effective in the diagnosis of iron deficiency anaemia (IDA), yielding a 33.9-percent yield in this study, with 65.8 percent of patients undergoing further workup and 12.7 percent requiring therapeutic intervention.
Tristan Manalac, 3 days ago
Minimally invasive pancreatectomy (MIP) offers a feasible alternative to open pancreatectomy (OP) for the treatment of pancreatic neuroendocrine neoplasms (PNEN), according to a recent Singapore study has found.
Yesterday
The perception that proton pump inhibitors (PPIs) cause multiple serious adverse effects (AEs) is supported by many internists, who then recommend treatment cessation even in patients at high risk for upper gastrointestinal bleeding (UGIB), reveals a study.
21 May 2020
At the 13th Annual Scientific Meeting of the Malaysian Osteoporosis Society (MOS), Dr Chan Siew Pheng discussed the role of alfacalcidol (One-Alpha®) in the treatment of osteoporosis (OP) and presented several patient profiles where alfacalcidol exhibited efficacy in increasing bone mineral density (BMD).

Nocturia likely to cause rather than result from depressive symptoms

27 Apr 2020

A bidirectional relationship exists between nocturia and depressive symptoms, a recent study has shown.

Moreover, the cross-lagged path coefficient suggests that nocturia is more likely to be a cause rather than a result of depressive symptoms, according to the investigators.

This longitudinal analysis was part of the Nagahama Cohort Project, a population-based cohort study, with baseline and 5-year follow-up investigations to assess the directional link between nocturia and depressive symptoms in the general population.

The investigators used self-report questionnaires, the International Prostate Symptom Score and the 5-item Mental Health Inventory to measure nocturnal voiding frequency and mental health. They also performed logistic regression and cross-lagged panel analyses to examine the bidirectional relationship between nocturia and depressive symptoms.

Data from 8,285 of 9,764 participants (median age, 57.3 years; 32.0 percent men) at baseline were analysed. New-onset depressive symptoms were observed in 369 participants and nocturia in 793.

Adjusted logistic regression analyses revealed a clear dose-relationship between baseline nocturnal voiding frequency and new-onset depressive symptoms (ptrend<0.001) and a weak association between baseline 5-item Mental Health Inventory and new-onset nocturia (ptrend=0.0087).

In cross-lagged panel analysis, the path coefficient from nocturnal voiding frequency to 5-item Mental Health Inventory (β, –0.06; p<0.001) was stronger compared to that from 5-item Mental Health Inventory to nocturnal voiding frequency (β, –0.02; p=0.047). This suggested that nocturia could more likely be a cause than a result of depressive symptoms.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
The use of capsule endoscopy (CE) appears to be effective in the diagnosis of iron deficiency anaemia (IDA), yielding a 33.9-percent yield in this study, with 65.8 percent of patients undergoing further workup and 12.7 percent requiring therapeutic intervention.
Tristan Manalac, 3 days ago
Minimally invasive pancreatectomy (MIP) offers a feasible alternative to open pancreatectomy (OP) for the treatment of pancreatic neuroendocrine neoplasms (PNEN), according to a recent Singapore study has found.
Yesterday
The perception that proton pump inhibitors (PPIs) cause multiple serious adverse effects (AEs) is supported by many internists, who then recommend treatment cessation even in patients at high risk for upper gastrointestinal bleeding (UGIB), reveals a study.
21 May 2020
At the 13th Annual Scientific Meeting of the Malaysian Osteoporosis Society (MOS), Dr Chan Siew Pheng discussed the role of alfacalcidol (One-Alpha®) in the treatment of osteoporosis (OP) and presented several patient profiles where alfacalcidol exhibited efficacy in increasing bone mineral density (BMD).